Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Sands

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Current Opinion in Gastroenterology|October 7, 2006
Treatment of ulcerative colitisC J Ooi, B E Sands
Alimentary Pharmacology & Therapeutics|June 21, 2005
Review article: practical management of inflammatory bowel disease patients taking immunomodulatorsC A Siegel, B E Sands
Gastroenterology|December 2, 1999
New life in a sleeper: thalidomide and Crohn's diseaseB E Sands, D K Podolsky
Inflammatory Bowel Diseases|August 1, 1998
Biologic agents: data in adults and childrenB E Sands, H S Winter
Annual Review of Physiology|January 1, 1996
The trefoil peptide familyB E Sands, D K Podolsky
The American Journal of Gastroenterology|November 8, 2011
Biologics in fistulizing Crohn's disease: so near, yet so farA Atreja, R Bahuva, B E Sands
Alimentary Pharmacology & Therapeutics|October 13, 2007
Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysisG G Kaplan, C Hur, J Korzenik, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2011
Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel diseaseA Tinsley, E A Macklin, J R Korzenik, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2015
Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's diseaseS C Shah, J-F Colombel, B E Sands, et al.
Alimentary Pharmacology & Therapeutics|May 12, 2016
Letter: mucosal healing is associated with improved long-term outcomes in Crohn's disease - authors' replyS C Shah, J-F Colombel, B E Sands, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Current Opinion in Gastroenterology|October 7, 2006
Treatment of ulcerative colitisC J Ooi, B E Sands
Alimentary Pharmacology & Therapeutics|June 21, 2005
Review article: practical management of inflammatory bowel disease patients taking immunomodulatorsC A Siegel, B E Sands
Gastroenterology|December 2, 1999
New life in a sleeper: thalidomide and Crohn's diseaseB E Sands, D K Podolsky
Inflammatory Bowel Diseases|August 1, 1998
Biologic agents: data in adults and childrenB E Sands, H S Winter
Annual Review of Physiology|January 1, 1996
The trefoil peptide familyB E Sands, D K Podolsky
The American Journal of Gastroenterology|November 8, 2011
Biologics in fistulizing Crohn's disease: so near, yet so farA Atreja, R Bahuva, B E Sands
Alimentary Pharmacology & Therapeutics|October 13, 2007
Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysisG G Kaplan, C Hur, J Korzenik, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2011
Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel diseaseA Tinsley, E A Macklin, J R Korzenik, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2015
Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's diseaseS C Shah, J-F Colombel, B E Sands, et al.
Alimentary Pharmacology & Therapeutics|May 12, 2016
Letter: mucosal healing is associated with improved long-term outcomes in Crohn's disease - authors' replyS C Shah, J-F Colombel, B E Sands, et al.
Pageof 4